echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The situation of drug use in Chinese hospitals has been made public, and 182 drugs have been completely delisted

    The situation of drug use in Chinese hospitals has been made public, and 182 drugs have been completely delisted

    • Last Update: 2019-10-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On October 11, the China Pharmaceutical Association released the monitoring report on hospital drug use of China Pharmaceutical Association in 2018 The situation of hospital drug use in China was open, and the drugs with the largest use and the highest sales were announced The information on the official website of the Pharmaceutical Association shows that all the chemicals and biological products purchased by the continuous sample hospitals in 2014-2018, the varieties included in the national essential drug catalog (2012 version) and the national essential drug catalog (2018 version), the national essential medical insurance, industrial injury insurance and maternity insurance drug catalog (2009 version) and the national basic medical insurance, industrial The catalogue of injury insurance and maternity insurance drugs (2017 Edition) includes three parts: varieties, amount of use and frequency of use It analyzes the use of hospital drugs in 2018 and the trend change in recent five years, and compares the update and change of 2012 edition of national essential drugs catalogue and 2018 edition of national essential drugs catalogue According to the report, from the perspective of drug varieties: in 2018, the total number of drug varieties in sample hospitals was 2194 From the perspective of hospital level, the total number of drug varieties used in tertiary hospitals was 2166, and the total number of drug varieties used in secondary and lower hospitals was 1952 From the regional perspective, the number of total drugs used in hospitals in the eastern region is the most, 2068; the number in the central region is the second, 1929; the number in the northeast region is the least, 1724 In terms of ATC categories, the varieties of cardiovascular system drugs and systemic hormone preparations account for a relatively high proportion, and the top four categories account for nearly 50% of all varieties In the past five years, the total number of drugs used in hospitals at all levels showed that the demand for the number of drugs used was basically stable; the number of varieties used in different ATC categories was relatively stable, and in recent years, the highest increase in the number of varieties was anti-tumor and immunomodulator It is worth noting that in the past five years, the total number of products in sample hospitals has decreased slightly, from 2231 in 2014 to 2194 in 2018, with 182 varieties withdrawn, 145 new varieties added and 37 varieties reduced From the analysis of the amount and frequency of drug use: in 2018, the total amount of drug use in tertiary hospitals was 4.7 times of that in secondary and lower hospitals From the perspective of region, the total drug use amount of hospitals in the eastern region is the largest, and that in the northeast is the smallest The total use amount of hospitals in the eastern region is twice of that in the northeast In 2018, the use frequency of the tertiary hospitals is nearly three times that of the secondary and lower hospitals From the regional perspective, the frequency of all hospitals in the eastern region is the highest, and the lowest in the northeast region The frequency of all hospitals in the eastern region is 2.4 times of that in the northeast region Due to the long length of the original report, only some screenshots of the report are shown below (Note: the full text of the report can be downloaded at the end of the article): appendix: 2018 hospital medication monitoring report of China Pharmaceutical Association (chemical and biological products) Pdf
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.